A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

NCT02307474 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding Unavailable

Conditions

Clear Cell Renal Cell Carcinoma
Renal Cell Carcinoma

Interventions

RADIATION: Stereotactic Radiosurgery
DRUG: Pazopanib Hydrochloride

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]